Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Buys Molecular Imaging in Bid to Expand Nanotech Imaging Business

NEW YORK, Nov. 29 (GenomeWeb News) - Agilent Technologies has acquired privately held Molecular Imaging for an undisclosed amount, the company announced today.


Tempe, Ariz.-based Molecular Imaging makes PicoPlus, a line of atomic force microscopes, which comprise a significant portion of the $1 billion market for nanotechnology imaging and measurement tools.


Agilent's chief business areas are electronic measurements and analytical measurements. With this acquisition, Agilent expands its nanotechnology imaging portfolio.


Since Molecular Imaging has an ongoing relationship with Arizona State University extending back to 1993, Agilent will not move operations from Tempe, the company said. Molecular Imaging's employees have joined Agilent, the company said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.